eTARGET

Click HereClick Here
Previous
Next

eTARGET supporting Molecular Tumour Boards

• DHP Purpose – Interpretation

• Licence – MIT /GLP 3.0

• Maturity – Multi Centre

eTARGET has overcome the challenge of integrating data from disparate sources in different organisations.
It presents a single view of patient clinical and genomic NGS data to support decision making for an MTB.

Key Features

Clinical

Integrates clinical and genomic data to support decision making by Molecular Tumour Boards. Developed by the Manchester Cancer Research Centre as part of the TARGET trial (Tumour chARacterisation to Guide Experimental Targeted therapy)

Data

Integrates clinical, tumour NGS and circulating tumour DNA NGS data

Technical

eTARGET is a web solution deployed within Microsoft Azure

GITHUB REPOSITORIES:

Front-end and web services (MIT Licence)

Data Ingest Process (GLP 3.0 Licence)